Phase I Dose-escalation Study of Two Doses GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults
Condition:   Influenza, Avian Interventions:   Biological: GHB04L1;   Other: Placebo Sponsor:   AVIR Green Hills Biotechnology AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2018 Category: Research Source Type: clinical trials

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults
Condition:   Influenza, Avian Interventions:   Biological: GHB04L1;   Other: Placebo Sponsor:   AVIR Green Hills Biotechnology AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2018 Category: Research Source Type: clinical trials

Improving Communication During a Pandemic Flu Outbreak
Condition:   Healthy Interventions:   Other: Agency Assignment framing;   Other: Attribute framing Sponsors:   King's College London;   National Institute for Health Research, United Kingdom;   Public Health England Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2018 Category: Research Source Type: clinical trials

Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial
ConclusionsSimulated activation is useful as a means to test, and prepare for, the rapid activation of ‘hibernating’ research studies. Whether simulation exercises can also help reduce waste in complex clinical trial research deserves further exploration.Trial registrationEudraCT Number 2013-001051-12,ISRCTN72331452. Registered on 6 March 2013. (Source: Trials)
Source: Trials - November 16, 2017 Category: Research Source Type: clinical trials

Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial
DiscussionPrevention and identification of children with a high risk of developing T2D could help to improve their cardiovascular health and to reduce the comorbidities associated with obesity.Trial registrationClinicalTrials.gov, ID:NCT03027726. Registered on 16 January 2017. (Source: Trials)
Source: Trials - August 10, 2017 Category: Research Source Type: clinical trials

Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)
Condition:   Influenza Intervention:   Biological: FluMist® Sponsors:   Stanford University;   National Institute of Allergy and Infectious Diseases (NIAID) Completed - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2017 Category: Research Source Type: clinical trials

Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
Condition:   TuberculosisInterventions:   Drug: etoricoxib;   Biological: H56:IC31Sponsors:   Anne Margarita Dyrhol Riise;   University of Oslo;   Statens Serum InstitutNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2015 Category: Research Source Type: clinical trials